Mindaugas Galvosas, MD

@mgalvosas.bsky.social

Neuroscience Digital Biomarkers @ indivi.io | prev. cough as a digital biomarker @ hyfe.com; founder of wandering prevention tech for dementia | interested in Digital Health | my opinions

A team from Revel Pharmaceuticals, Calico and CU Anschutz just published an enzyme that removes a form of chemical aging damage previously considered permanent Nature Communications, July 2026 → The claim isn't "slowed accumulation" It's reversal of damage

Bild

Built a personalized app for my wife Kanji and kana practice with a custom set of words of interest: niche food specialties, Geiko/Maiko daily life, Tale of Genji etc iPad pencil stroke order practice (watch / guided / trace) A reactive matcha buddy in-app Thanks, Claude

Bild

Digital biomarkers should not only aim to become primary endpoint measures. There’s immense potential value to clinical drug development beyond primary endpoint status: ->reducing screen-failure rate ->interim marker of early termination ->pre-screening for placebo response

AusculPatch is taped to the chest, over peripheral arteries - continuously captures subtle vibrations produced by the heart, lungs, blood flow, and pulse waves Are patch devices really suitable for continuous measures? Doubting due to discomfort by many www.mobihealthnews.com/news/anz/aus...

Australian engineers develop wearable steth patch for remote monitoring

AusculPatch, which records heart, breathing and pulse signals, is set for AI-assisted deterioration detection testing.

mobihealthnews.com